Search
Search Results
##search.searchResults.foundPlural##
-
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3264PDF: 563HTML: 630 -
GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
2668PDF: 968HTML: 397TABLE: 168FIGURES: 206 -
MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS
3245PDF: 688HTML: 697Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 163Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 159Table : Distribution of the sites of bleeding and their causes: 163 -
ADVANCES IN THE TREATMENT OF MALARIA
2776PDF: 1089HTML: 5974 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
1981PDF: 1162Html: 258 -
-
Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia
2849PDF: 661HTML: 1918figure 1: 145figure 2: 159 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1303PDF: 852HTML: 1755 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3408PDF: 843HTML: 1620figure 1: 148Untitled: 172 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
5924PDF: 3083HTML: 8985Figure Malaria Ricci: 203 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
898PDF: 327HTML: 164 -
ADVERSE PREGNANCY OUTCOMES IN SICKLE CELL TRAIT: A PROSPECTIVE COHORT STUDY EVALUATING CLINICAL AND HAEMATOLOGICAL PARAMETERS IN POSTPARTUM MOTHERS AND NEW-BORNS. Sickle cell trait pregnancy and outcomes
1231PDF: 1156HTML: 437 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3620PDF: 1204HTML: 3862Untitled: 185Untitled: 240 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2432PDF: 814HTML: 8787Efremov 1: 204Efremov 2: 163 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1159PDF: 731HTML: 296 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1494PDF: 944HTML: 153 -
“Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency. Hemolysis by Hemolysis and G6PD deficiency.
1199PDF: 940HTML: 307 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
884PDF: 524Html: 143 -
FIRST-PHASE INSULIN RESPONSE (FPIR) TO INTRAVENOUS GLUCOSE TOLERANCE TEST (IVGTT), INSULIN SENSITIVITY AND LONG-TERM FOLLOW-UP IN TRANSFUSION-DEPENDENT BETA-THALASSEMIA (TDT) NORMOGLYCEMIC PATIENTS WITH REDUCED INSULIN SECRETION TO ORAL GLUCOSE TOLERANCE TEST: A PILOT STUDY. The function of the endocrine pancreas in transfusion-dependent ?-thalassemia
7214PDF: 514HTML: 219 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3516PDF: 1077HTML: 23314 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
3723PDF: 3056HTML: 182 -
EPIDEMIOLOGY OF MALARIA IN THE STATE OF QATAR, 2008-2015
1857PDF: 942HTML: 411 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1772PDF: 874HTML: 930Referring article: 715 -
DISSEMINATED HISTOPLASMOSIS IN IMMUNOCOMPETENT INDIVIDUALS- NOT A SO RARE ENTITY
2306PDF: 1072HTML: 2146Untitled: 140 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2252PDF: 935HTML: 7605Untitled: 253Fig2: 162Fig3: 142Fig4: 161 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1173PDF: 550HTML: 2839ATRA induced Reactive Hemophagocytosis: A Case Report: 172







